Understanding the mechanical properties of human veins

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to characterize the mechanical properties of human saphenous and popliteal veins that are typically discarded after varicose vein procedures, lower limb amputations, and bypass surgeries. By analyzing the stress-stretch relationship of these vein segments, the study seeks to enhance the understanding of treatment techniques and improve the design of mechanical devices. The findings could also help assess the suitability of these veins as conduits for bypass and arteriovenous fistula procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or Female patients aged 18 years or older
* Patients undergoing varicose vein procedures or;
* Patients undergoing lower limb amputation or;
* Patients undergoing lower limb bypass surgery

Exclusion Criteria:

* Patients unable to give informed consent
* Seriously ill/unconscious patients

Where it's running

• University Hospital Limerick
  Limerick, Limerick, Ireland Recruiting

Study contacts

• Principal investigator: Eamon Kavanagh, MD FRCSI — University Hospital of Limerick
• Study coordinator: Fiona Leahy, CNM Research
• Email: fionac.leahy@hse.ie
• Phone: 061588394

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MRI-guided management of occlusive peripheral arterial disease

  This study is testing how MRI scans can help doctors understand plaque in the arteries of people with peripheral arterial disease and see if certain devices can make treatments safer.

  Recruiting The Methodist Hospital Research Institute · Houston, Texas · NCT06782100

• Automated carbon dioxide-guided angiography to spare iodinated dye during lower‑leg artery procedures

  This trial tests whether using automated carbon dioxide injections with a contrast‑sparing approach during infrainguinal peripheral vascular interventions reduces serious kidney problems within 90 days in adults with peripheral artery disease and reduced kidney function.

  Recruiting at 8 sites Phase 3 University of Leipzig · Innsbruck and 10 other locations · NCT06656988

• Using Fisetin to Improve Walking in Patients with Peripheral Arterial Disease

  This study is testing if Fisetin can help people with peripheral artery disease walk better by reducing certain old cells in their bodies.

  Recruiting Phase 2 Northwestern University · Chicago, Illinois · NCT06399809

• Effects of a medication on blood vessel function and walking ability in people with peripheral artery disease

  This study is testing if a medication called diroximel fumarate can help improve blood vessel function and walking ability in people aged 50-75 with peripheral artery disease.

  Recruiting Early Phase 1 University of Nebraska · Omaha, Nebraska · NCT06319339

• Using computerized alerts to improve cholesterol treatment in patients with Peripheral Artery Disease

  This study is testing a new computer alert system to see if it can help doctors prescribe cholesterol-lowering medications more often for patients with Peripheral Artery Disease who aren't currently on them.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT06300450

• Exercise and beetroot juice for improving walking in patients with PAD

  This study is testing whether combining treadmill and home exercises with beetroot juice can help older patients with peripheral artery disease walk farther and feel better.

  Recruiting at 3 sites Phase 3 Northwestern University · Chicago, Illinois and 2 other locations · NCT06032065

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.